DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Kataoka Y, Mukohara T, Shimada H. et al.
Association between gain-offunction mutations in PIK3CA and resistance to HER2-targeted agents in HER2-amplified breast cancer cell lines.
Ann Oncol 2010;
21: 255-262
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.